[
    [
        {
            "time": "2023-10-10",
            "original_text": "智飞生物(300122.SZ)：股东吴冠江累计减持5%股份 减持股份",
            "features": {
                "keywords": [
                    "智飞生物",
                    "吴冠江",
                    "减持",
                    "5%股份"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "智飞生物(300122.SZ)：股东吴冠江累计减持5%股份 减持股份",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "智飞生物(300122.SZ)遭股东吴冠江减持约8000万股 减持股份",
            "features": {
                "keywords": [
                    "智飞生物",
                    "吴冠江",
                    "减持",
                    "8000万股"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "智飞生物(300122.SZ)遭股东吴冠江减持约8000万股 减持股份",
                "Correlation": 10,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "智飞生物(300122.SZ)股东吴冠江及其一致行动人拟减持不超2960万股 拟减持股份",
            "features": {
                "keywords": [
                    "智飞生物",
                    "吴冠江",
                    "一致行动人",
                    "拟减持",
                    "2960万股"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "智飞生物(300122.SZ)股东吴冠江及其一致行动人拟减持不超2960万股 拟减持股份",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "智飞生物：股东吴冠江先生及一致行动人拟合计减持不超过1.85% 拟减持股份",
            "features": {
                "keywords": [
                    "智飞生物",
                    "吴冠江",
                    "一致行动人",
                    "拟减持",
                    "1.85%"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "智飞生物：股东吴冠江先生及一致行动人拟合计减持不超过1.85% 拟减持股份",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "智飞生物：持股5%以上股东吴冠江计划减持不超过1.85%股份 拟减持股份",
            "features": {
                "keywords": [
                    "智飞生物",
                    "吴冠江",
                    "持股5%",
                    "拟减持",
                    "1.85%"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "智飞生物：持股5%以上股东吴冠江计划减持不超过1.85%股份 拟减持股份",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-10",
            "original_text": "智飞生物现2笔大宗交易 共成交29,332.53万元",
            "features": {
                "keywords": [
                    "智飞生物",
                    "大宗交易",
                    "2笔",
                    "29,332.53万元"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "智飞生物现2笔大宗交易 共成交29,332.53万元",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]